Indian Navy invites applications for 2025 Civilian Boat Crew Staff Recruitment for Group 'C' posts, including Syrang of ...

Investing.com -- Shares of MeiraGTx Holdings plc ( Nasdaq: NASDAQ: MGTX) climbed 13% following the announcement of a strategic collaboration with Hologen AI, aimed at accelerating the Phase 3 ...

SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, today announced that it has dosed the first patient in the ...

The Toronto Blue Jays failed to extend Vladimir Guerrero Jr. this offseason, and all signs point to him hitting free agency ...

The New England Patriots made one of the biggest splashes on Day 1 of NFL free agency, swooping in ahead of the Carolina ...

Lost a little bit in the shuffle of the hectic NHL trade deadline was the contract extension for Columbus Blue Jackets’ ...

Follow along here during the entire final day of NHL trade action for news and analysis of all the biggest moves.

The Athletic has live coverage of the 2025 NHL trade deadline. Penguins get: Forward Tommy Novak, defenseman Luke Schenn ...

Amidst an unceasing news cycle in the NFL this week, one storyline in particular could have a significant effect on how the Pittsburgh Steelers go about conducting business this offseason. There's a ...

“We are thrilled to welcome these industry-leading experts to our Clinical and Scientific Advisory Board,” said Dr. Nicole K. Paulk, CEO, Founder, and President of Siren Biotechnology. “Their deep ...

OPGx-MERTK is a gene therapy being developed by Opus Genetics to treat patients impacted by MERTK-related retinitis pigmentosa (RP). Results from a pre-clinical study which evaluated OPGx-MERTK in a ...

Zeitler likely won't break the bank in terms of years or AAV, making it a viable option for Detroit. Onwuzurike stayed fully ...